![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/57 | (2006.01) |
A61K 31/57 | (2013.01) | ||
A61K 31/565 | (2006.01) | ||
A61K 9/1075 | (2013.01) | ||
A61K 47/14 | (2017.01) | ||
A61P 15/00 | (2018.01) | ||
A61P 5/34 | (2018.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 47/10 | (2017.01) | ||
A61P 5/24 | (2018.01) | ||
A61K 9/107 | (2006.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 9/48 | (2006.01) | ||
A61K 47/10 | (2013.01) | ||
A61K 31/565 | (2013.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 15/12 | (2018.01) | ||
A61P 15/06 | (2018.01) | ||
A61K 47/14 | (2013.01) | ||
A61P 5/30 | (2018.01) | ||
A61K 9/48 | (2013.01) |
(11) | Number of the document | 3560500 |
(13) | Kind of document | T |
(96) | European patent application number | 19163006.0 |
Date of filing the European patent application | 2013-06-18 | |
(97) | Date of publication of the European application | 2019-10-30 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-22 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201261661302 P | 2012-06-18 | US | |
201261662265 P | 2012-06-20 | US | |
201213684002 | 2012-11-21 | US | |
PCT/US2013/023309 | 2013-01-25 | WO | |
201313843362 | 2013-03-15 | US |
(72) |
CACACE, Janice Louise , US
PERSICANER, Peter H.R. , US
|
(73) |
TherapeuticsMD, Inc. ,
951 Yamato Road, Suite 220, Boca Raton, FL 33431,
US
|
(54) | PROGESTERONE FORMULATIONS |
PROGESTERONE FORMULATIONS |